These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8272047)

  • 1. Performance evaluation program for Mycobacterium tuberculosis drug-susceptibility testing process.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jan; 43(1):17-8. PubMed ID: 8272047
    [No Abstract]   [Full Text] [Related]  

  • 2. From the Centers for Disease Control and Prevention. Performance evaluation program for Mycobacterium tuberculosis drug-susceptibility testing process.
    JAMA; 1994 Feb; 271(5):341. PubMed ID: 8283573
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mycobacterium tuberculosis with extensive resistance].
    Labie D
    Med Sci (Paris); 2007 Feb; 23(2):205-9. PubMed ID: 17291432
    [No Abstract]   [Full Text] [Related]  

  • 4. New generation methods for drug susceptibility testing for tuberculosis.
    Katoch VM
    Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
    Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-resistant tuberculosis: reality and potential threat.
    Lalloo UG
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of primary drug resistance of Mycobacterium tuberculosis from two hospitals in Tenerife, Canary Islands, Spain (1990-1997).
    Lecuona M; Alvarez R; Quintero J; Torres A; Hernández AM; Montesinos I; Sierra A
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):186-7. PubMed ID: 10694101
    [No Abstract]   [Full Text] [Related]  

  • 8. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 9. The "source" of drug-resistant TB outbreaks.
    van Helden PD; Victor T; Warren RM
    Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 11. Systematic drug susceptibility testing: a necessary component of the 'DOTS plus' strategy?
    Grosset PJ
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):549-50. PubMed ID: 10423215
    [No Abstract]   [Full Text] [Related]  

  • 12. [Multidrug-resistant tuberculosis].
    Mori T
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):192-4. PubMed ID: 10088371
    [No Abstract]   [Full Text] [Related]  

  • 13. Standardisation of sensitivity tests.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):69-70. PubMed ID: 9562114
    [No Abstract]   [Full Text] [Related]  

  • 14. CDC advises on management of persons exposed to multiple-drug-resistant tuberculosis.
    Clin Pharm; 1992 Dec; 11(12):991, 994, 999. PubMed ID: 1337505
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA).
    Drowart A; Cambiaso CL; Huygen K; Serruys E; Portaels F; Jann E; Van Vooren JP
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):284-8. PubMed ID: 9432378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug susceptibility of tuberculosis isolates in Kansas, 1992-1993.
    Kans Med; 1994 Jun; 95(6):147-8. PubMed ID: 7933767
    [No Abstract]   [Full Text] [Related]  

  • 17. Transmission in the United States Virgin Islands and Florida of a multidrug-resistant Mycobacterium tuberculosis strain acquired in Puerto Rico.
    Reichler MR; Valway SE; Onorato IM
    Clin Infect Dis; 2000 Mar; 30(3):617-8. PubMed ID: 10722464
    [No Abstract]   [Full Text] [Related]  

  • 18. High rates of multidrug-resistant Mycobacterium tuberculosis in Sinaloa State, Mexico.
    Zazueta-Beltran J; Muro-Amador S; Flores-Gaxiola A; Llausas-Magaña E; León-Sicairos N; Canizalez-Roman A
    J Infect; 2007 Apr; 54(4):411-2. PubMed ID: 16730800
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis].
    Katalinić-Janković V; Obrovac M
    Acta Med Croatica; 2004; 58(4):323-8. PubMed ID: 15700689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs.
    Ann Pharmacother; 2006 May; 40(5):1007-8. PubMed ID: 16670365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.